National Bank of Canada
PFE icon

National Bank of Canada’s Pfizer PFE Stock Holding History

National Bank of Canada’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2M Buy
+20,000
New +$523K 0.03% 359
2023
Q1 		– Sell
-8,000
Closed -$41M – 2825
2022
Q4 		$41M Buy
+8,000
New +$384K 0.1% 171

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

National Bank of Canada's PFE Position: Q2 2026 in Review

National Bank of Canada reduced its Pfizer (PFE) stake by 32% in Q2 2026, selling an estimated $42.7M and leaving 3,503,491 shares worth $84.4M. The position accounts for 0.06% of the portfolio, ranked #242.

National Bank of Canada first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $453M in Q3 2023. 1,973 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • National Bank of Canada held 3,503,491 shares of Pfizer worth $84.4M as of Q2 2026.
  • National Bank of Canada sold 1,632,776 Pfizer shares in Q2 2026, an estimated $42.7M.
  • Pfizer made up 0.06% of National Bank of Canada's portfolio in Q2 2026, its #242 holding.
  • National Bank of Canada first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Pfizer position peaked at $453M in Q3 2023.
  • 1,973 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.